Healthpeak Properties, Inc.

NYSE:DOC Stock Report

Market Cap: US$14.3b

Healthpeak Properties Valuation

Is DOC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DOC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: DOC ($20.3) is trading below our estimate of future cash flow value ($37.07)

Significantly Below Future Cash Flow Value: DOC is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DOC?

Key metric: As DOC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for DOC. This is calculated by dividing DOC's market cap by their current earnings.
What is DOC's PE Ratio?
PE Ratio57.7x
EarningsUS$242.74m
Market CapUS$14.31b

Price to Earnings Ratio vs Peers

How does DOC's PE Ratio compare to its peers?

The above table shows the PE ratio for DOC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average56.3x
OHI Omega Healthcare Investors
16.9x-7.95%US$14.9b
AHR American Healthcare REIT
102.4x28.04%US$12.6b
SBRA Sabra Health Care REIT
80.1x30.04%US$5.3b
CTRE CareTrust REIT
25.7x18.94%US$9.2b
DOC Healthpeak Properties
57.7x-25.15%US$14.3b

Price-To-Earnings vs Peers: DOC is good value based on its Price-To-Earnings Ratio (57.7x) compared to the peer average (66.5x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does DOC's PE Ratio compare vs other companies in the Global Health Care REITs Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
DOC 57.7xIndustry Avg. 17.1xNo. of Companies7PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: DOC is expensive based on its Price-To-Earnings Ratio (57.7x) compared to the Global Health Care REITs industry average (17.1x).

Price to Earnings Ratio vs Fair Ratio

What is DOC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DOC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio57.7x
Fair PE Ratio22.8x

Price-To-Earnings vs Fair Ratio: DOC is expensive based on its Price-To-Earnings Ratio (57.7x) compared to the estimated Fair Price-To-Earnings Ratio (22.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DOC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$20.30
US$23.05
+13.56%
10.83%US$29.00US$17.00n/a19
Sep ’27US$20.82
US$23.05
+10.72%
10.83%US$29.00US$17.00n/a19
Aug ’27US$21.83
US$22.39
+2.59%
11.09%US$29.00US$17.00n/a19
Jul ’27US$21.64
US$21.44
-0.90%
12.26%US$29.00US$17.00n/a18
Jun ’27US$19.00
US$20.94
+10.23%
12.78%US$29.00US$17.00n/a18
May ’27US$16.42
US$19.47
+18.59%
16.25%US$29.00US$16.00n/a18
Apr ’27US$16.38
US$19.84
+21.15%
16.61%US$29.00US$16.00n/a16
Mar ’27US$17.68
US$19.88
+12.42%
16.48%US$29.00US$16.00n/a16
Feb ’27US$17.24
US$20.06
+16.33%
15.54%US$29.00US$17.00n/a18
Jan ’27US$16.08
US$20.58
+28.01%
14.63%US$29.00US$17.00n/a18
Dec ’26US$18.19
US$20.92
+14.99%
13.71%US$29.00US$18.00n/a18
Nov ’26US$17.95
US$21.03
+17.15%
13.46%US$29.00US$18.00n/a18
Oct ’26US$19.18
US$21.25
+10.79%
13.81%US$29.00US$18.00n/a18
Sep ’26US$17.94
US$21.47
+19.67%
14.44%US$29.00US$18.00US$20.8216
Aug ’26US$16.77
US$22.34
+33.24%
14.08%US$29.00US$18.00US$21.8316
Jul ’26US$17.88
US$22.62
+26.50%
12.72%US$29.00US$18.00US$21.6417
Jun ’26US$17.41
US$23.26
+33.63%
10.89%US$29.00US$20.00US$19.0017
May ’26US$17.78
US$24.09
+35.48%
8.90%US$29.00US$21.00US$16.4217
Apr ’26US$20.02
US$24.68
+23.26%
7.25%US$29.00US$22.00US$16.3817
Mar ’26US$20.46
US$24.74
+20.90%
7.21%US$29.00US$22.00US$17.6817
Feb ’26US$20.66
US$25.29
+22.43%
8.58%US$30.50US$22.00US$17.2417
Jan ’26US$20.27
US$25.32
+24.93%
8.67%US$30.50US$22.00US$16.0817
Dec ’25US$21.99
US$25.62
+16.50%
7.82%US$30.50US$23.00US$18.1917
Nov ’25US$21.98
US$25.53
+16.15%
8.21%US$30.50US$22.00US$17.9517
Oct ’25US$22.67
US$24.47
+7.94%
10.14%US$30.50US$20.00US$19.1817
Sep ’25US$22.28
US$24.12
+8.25%
10.94%US$30.50US$20.00US$17.9417
US$23.05
Fair Value
11.9% undervalued intrinsic discount
19
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/11 22:11
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Healthpeak Properties, Inc. is covered by 38 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jacob KilsteinArgus Research Company
David RodgersBaird
Adam FeinsteinBarclays